Table 1 Patient characteristics
From: Locally advanced thymoma; does neoadjuvant chemotherapy make a difference?
Variable | Number of patients n = 23 |
|---|---|
Age (years) | 46.28 (± 15.3) |
Gender | |
Male | 18 (78%) |
Female | 5 (22%) |
Comorbiditiesα | |
Diabetes mellitus | 3 (13%) |
Hypertension | 3 (13%) |
Otherβ | 5 (22%) |
Histologic subtypes | |
A | 1 (4%) |
AB | 4 (17%) |
BI | 1 (4%) |
BII | 8 (35%) |
BIII | 9 (39%) |
Staging of Masaoka | |
Stage I | 3 (13%) |
Stage II | 5 (22%) |
Stage III | 3 (13%) |
Stage IV | 12 (52%) |
Myasthenia graves | 5 (22%) |
Neoadjuvant chemotherapy | |
Stage I | 1 (8%) |
Stage III | 2 (16%) |
Stage IIV | 9 (75%) |
Surgical approach | |
VATSΩ | 11 (48%) |
Open | 12 (52%) |
Negative resection margin (R0) | 18 (78%) |